Advocacy intelligence hub — real-time data for patient organizations
National Institute of Cardiology, Warsaw, Poland
Crinetics Pharmaceuticals Inc. — PHASE3
Queen Mary University of London — NA
M.D. Anderson Cancer Center — PHASE2
M.D. Anderson Cancer Center — EARLY_PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Xermelo
Lexicon
Xermelo
(telotristat etiprate)Orphan drugstandardTerSera Therapeutics, LLC
12.1 Mechanism of Action Telotristat, the active metabolite of telotristat ethyl, is an inhibitor of tryptophan hydroxylase, which mediates the rate l...
Somatuline Depot
(Lanreotide)Orphan drugstandardIPSEN, Inc.
12.1 Mechanism of Action Lanreotide, the active component of SOMATULINE DEPOT is an octapeptide analog of natural somatostatin. The mechanism of actio...
Pablo Lapuerta, MD, MD
Lexicon Pharmaceuticals, Inc.
📍 SKILLMAN, NJ
Marianne Pavel, Professor
Charité Campus Virchow Klinikum, Berlin, Germany
Pablo LaPuerta, MD, MD
Lexicon Pharmaceuticals, Inc.
📍 SKILLMAN, NJ
Nageshwara V Dasari, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
James Yao
M.D. Anderson Cancer Center
Daniel M Halperin, MD, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX